

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.47084046 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.34231362 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.07773835 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.03417595 |
| 5 | vocalization behavior (GO:0071625) | 5.62068243 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.46503767 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.46484167 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.44842180 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41809073 |
| 10 | glutamate secretion (GO:0014047) | 5.35538026 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.20734964 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03067793 |
| 13 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.00132048 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.95134103 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.85108733 |
| 16 | protein localization to synapse (GO:0035418) | 4.76400648 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.75296124 |
| 18 | exploration behavior (GO:0035640) | 4.61074931 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.54662228 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.51975118 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.41211926 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.33888229 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 4.29046500 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.28397563 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.25053262 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.18289147 |
| 27 | long-term memory (GO:0007616) | 4.10997886 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.10439273 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.10293737 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 4.07369232 |
| 31 | positive regulation of membrane potential (GO:0045838) | 4.04842140 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.01322212 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.01120781 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.97841061 |
| 35 | regulation of synaptic plasticity (GO:0048167) | 3.97179564 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.88217706 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.85412292 |
| 38 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.83613563 |
| 39 | proline transport (GO:0015824) | 3.74576115 |
| 40 | long-term synaptic potentiation (GO:0060291) | 3.73064990 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.69921086 |
| 42 | neuromuscular process controlling balance (GO:0050885) | 3.69683940 |
| 43 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.68387168 |
| 44 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.65694776 |
| 45 | sodium ion export (GO:0071436) | 3.64626784 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.63374405 |
| 47 | positive regulation of neurotransmitter transport (GO:0051590) | 3.58795218 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.57172617 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.54852358 |
| 50 | regulation of apoptotic cell clearance (GO:2000425) | 3.52619655 |
| 51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.51433909 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.50526898 |
| 53 | neurotransmitter transport (GO:0006836) | 3.48450146 |
| 54 | prepulse inhibition (GO:0060134) | 3.47009628 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.43214078 |
| 56 | auditory behavior (GO:0031223) | 3.43204919 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.41148360 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.37595779 |
| 59 | dendritic spine organization (GO:0097061) | 3.37518632 |
| 60 | regulation of vesicle fusion (GO:0031338) | 3.33688259 |
| 61 | regulation of dendritic spine development (GO:0060998) | 3.32703850 |
| 62 | behavioral defense response (GO:0002209) | 3.30151683 |
| 63 | behavioral fear response (GO:0001662) | 3.30151683 |
| 64 | neuron recognition (GO:0008038) | 3.29833767 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.28410309 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.27017917 |
| 67 | response to auditory stimulus (GO:0010996) | 3.26757536 |
| 68 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.23499943 |
| 69 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.22788422 |
| 70 | cerebellar granule cell differentiation (GO:0021707) | 3.22274014 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 3.21945468 |
| 72 | membrane depolarization (GO:0051899) | 3.20605621 |
| 73 | response to histamine (GO:0034776) | 3.20506036 |
| 74 | neuronal ion channel clustering (GO:0045161) | 3.19764364 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.19749918 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.18377836 |
| 77 | negative regulation of fibrinolysis (GO:0051918) | 3.17584583 |
| 78 | glycine transport (GO:0015816) | 3.17206663 |
| 79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16792838 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.16734854 |
| 81 | positive regulation of synaptic transmission (GO:0050806) | 3.16661746 |
| 82 | learning (GO:0007612) | 3.16352882 |
| 83 | neuromuscular process controlling posture (GO:0050884) | 3.15942349 |
| 84 | regulation of female receptivity (GO:0045924) | 3.12070799 |
| 85 | regulation of glutamate secretion (GO:0014048) | 3.11072878 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 3.10737638 |
| 87 | cellular sodium ion homeostasis (GO:0006883) | 3.10564427 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.10318563 |
| 89 | regulation of synaptic transmission (GO:0050804) | 3.08698086 |
| 90 | axonal fasciculation (GO:0007413) | 3.07448392 |
| 91 | fear response (GO:0042596) | 3.06171726 |
| 92 | lung epithelium development (GO:0060428) | 3.05250354 |
| 93 | behavioral response to cocaine (GO:0048148) | 3.05084921 |
| 94 | innervation (GO:0060384) | 3.03605614 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.03166772 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02571721 |
| 97 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02485072 |
| 98 | neuromuscular process (GO:0050905) | 3.01896937 |
| 99 | long term synaptic depression (GO:0060292) | 2.99031752 |
| 100 | chemosensory behavior (GO:0007635) | 2.97460277 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96831529 |
| 102 | postsynaptic membrane organization (GO:0001941) | 2.96794512 |
| 103 | membrane depolarization during action potential (GO:0086010) | 2.96403720 |
| 104 | synaptic transmission (GO:0007268) | 2.96280925 |
| 105 | negative regulation of amino acid transport (GO:0051956) | 2.95689112 |
| 106 | visual learning (GO:0008542) | 2.94952267 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94885707 |
| 108 | regulation of protein activation cascade (GO:2000257) | 2.80841428 |
| 109 | regulation of complement activation (GO:0030449) | 2.80440055 |
| 110 | cell-cell junction maintenance (GO:0045217) | 2.72973912 |
| 111 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.70647005 |
| 112 | protein carboxylation (GO:0018214) | 2.70647005 |
| 113 | regulation of fibrinolysis (GO:0051917) | 2.70039946 |
| 114 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.57965002 |
| 115 | intestinal cholesterol absorption (GO:0030299) | 2.55455567 |
| 116 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.54385111 |
| 117 | central nervous system myelination (GO:0022010) | 2.51532248 |
| 118 | axon ensheathment in central nervous system (GO:0032291) | 2.51532248 |
| 119 | L-phenylalanine catabolic process (GO:0006559) | 2.51198799 |
| 120 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.51198799 |
| 121 | sodium ion homeostasis (GO:0055078) | 2.51172241 |
| 122 | neuron remodeling (GO:0016322) | 2.50438692 |
| 123 | L-amino acid import (GO:0043092) | 2.49919167 |
| 124 | cell communication involved in cardiac conduction (GO:0086065) | 2.48845633 |
| 125 | positive regulation of dendrite development (GO:1900006) | 2.44632378 |
| 126 | regulation of plasminogen activation (GO:0010755) | 2.43421960 |
| 127 | cell volume homeostasis (GO:0006884) | 2.39560863 |
| 128 | amino acid import (GO:0043090) | 2.36949182 |
| 129 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.36540393 |
| 130 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.35702348 |
| 131 | cell junction maintenance (GO:0034331) | 2.35314348 |
| 132 | endothelial cell chemotaxis (GO:0035767) | 2.29525284 |
| 133 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.24575805 |
| 134 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.23772867 |
| 135 | blood coagulation, intrinsic pathway (GO:0007597) | 2.23718055 |
| 136 | regulation of ARF protein signal transduction (GO:0032012) | 2.23489379 |
| 137 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.22126599 |
| 138 | L-phenylalanine metabolic process (GO:0006558) | 2.22126599 |
| 139 | negative regulation of catenin import into nucleus (GO:0035414) | 2.22094578 |
| 140 | protein-lipid complex remodeling (GO:0034368) | 2.20576103 |
| 141 | macromolecular complex remodeling (GO:0034367) | 2.20576103 |
| 142 | plasma lipoprotein particle remodeling (GO:0034369) | 2.20576103 |
| 143 | reverse cholesterol transport (GO:0043691) | 2.19623993 |
| 144 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.18427343 |
| 145 | low-density lipoprotein particle remodeling (GO:0034374) | 2.17359394 |
| 146 | potassium ion homeostasis (GO:0055075) | 2.14589706 |
| 147 | nephron epithelium morphogenesis (GO:0072088) | 2.13435054 |
| 148 | nephron tubule morphogenesis (GO:0072078) | 2.13435054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.93684609 |
| 2 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19351634 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16656812 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16597904 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10492876 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.08990202 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.85049603 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.85049603 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77246598 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71127843 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.70887043 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68731103 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63663847 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61170928 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52831414 |
| 16 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52398187 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46576986 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46207174 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37152637 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.36242125 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.35582633 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28533343 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27287231 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25598082 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.25104872 |
| 26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21572903 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11115137 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.08533990 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90437820 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81059768 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81002191 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80577509 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79466918 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79231813 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71728258 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.69398557 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62472457 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58224746 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54867028 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54617575 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51251538 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50251645 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50177555 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47296196 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43875306 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42870906 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41218877 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41139591 |
| 49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38441100 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37792255 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36711195 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35870330 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33848899 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33002467 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32563609 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29480402 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27884468 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27189640 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26789297 |
| 60 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26656078 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26469929 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26279025 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25866834 |
| 64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25667271 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23364535 |
| 66 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23281406 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21343870 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20534297 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19608175 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18807942 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.18758195 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18295213 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15304191 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14450237 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14342516 |
| 76 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13638297 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13036115 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12164186 |
| 79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11564127 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10925468 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10568600 |
| 82 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10163656 |
| 83 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08762021 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05680534 |
| 85 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05282145 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03927685 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03808574 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03643703 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02474895 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02307614 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01976764 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01917911 |
| 93 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01297408 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00793014 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00692923 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00478421 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00311881 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00009321 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98892118 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98694487 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98194188 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97171795 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96940853 |
| 104 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96667794 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96347403 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96015521 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95785845 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95617795 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95581403 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95406796 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94578065 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94524454 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94445513 |
| 114 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94251640 |
| 115 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94041326 |
| 116 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93955813 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93799185 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93573959 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 0.93480589 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92017081 |
| 121 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91535972 |
| 122 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91477752 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90982613 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90729937 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90035238 |
| 126 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89602677 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89130616 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88535384 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87906773 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87784645 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87560518 |
| 132 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87131784 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86775447 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86558958 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85643902 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85255907 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83488602 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83327875 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82328800 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82304799 |
| 141 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81756910 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81167968 |
| 143 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80983462 |
| 144 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80722888 |
| 145 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79136683 |
| 146 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.78186887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.55785283 |
| 2 | MP0003880_abnormal_central_pattern | 5.00515400 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.47238641 |
| 4 | MP0002822_catalepsy | 4.38097972 |
| 5 | MP0000566_synostosis | 3.88352834 |
| 6 | MP0004270_analgesia | 3.73526256 |
| 7 | MP0009745_abnormal_behavioral_response | 3.72983914 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.61682561 |
| 9 | MP0002064_seizures | 3.32017293 |
| 10 | MP0009046_muscle_twitch | 2.90089882 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.90079915 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.88535009 |
| 13 | MP0001486_abnormal_startle_reflex | 2.61265865 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.59851646 |
| 15 | MP0002272_abnormal_nervous_system | 2.58432490 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.48456980 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.40006896 |
| 18 | MP0002736_abnormal_nociception_after | 2.16012160 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.05737890 |
| 20 | MP0001440_abnormal_grooming_behavior | 1.99867954 |
| 21 | MP0005365_abnormal_bile_salt | 1.97659582 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.95160532 |
| 23 | MP0005670_abnormal_white_adipose | 1.94697991 |
| 24 | * MP0010329_abnormal_lipoprotein_level | 1.88813491 |
| 25 | MP0003195_calcinosis | 1.88763799 |
| 26 | MP0003329_amyloid_beta_deposits | 1.88672213 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.88087002 |
| 28 | MP0008569_lethality_at_weaning | 1.85877776 |
| 29 | MP0001970_abnormal_pain_threshold | 1.83964114 |
| 30 | MP0004858_abnormal_nervous_system | 1.83940940 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.82989847 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.79505002 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.78650872 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77956446 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.73140113 |
| 36 | MP0005360_urolithiasis | 1.71394123 |
| 37 | MP0003879_abnormal_hair_cell | 1.69763458 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.68727177 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.66102433 |
| 40 | MP0004924_abnormal_behavior | 1.66102433 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.63735369 |
| 42 | MP0002184_abnormal_innervation | 1.51298247 |
| 43 | MP0000778_abnormal_nervous_system | 1.45904944 |
| 44 | MP0004885_abnormal_endolymph | 1.42723048 |
| 45 | MP0003633_abnormal_nervous_system | 1.40164591 |
| 46 | MP0000955_abnormal_spinal_cord | 1.39415340 |
| 47 | MP0001529_abnormal_vocalization | 1.38564951 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.36533988 |
| 49 | MP0001984_abnormal_olfaction | 1.36457466 |
| 50 | MP0003787_abnormal_imprinting | 1.29369150 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.29161215 |
| 52 | MP0002089_abnormal_postnatal_growth/wei | 1.27832009 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.25115460 |
| 54 | MP0008872_abnormal_physiological_respon | 1.16630719 |
| 55 | MP0001905_abnormal_dopamine_level | 1.16356683 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.15960026 |
| 57 | MP0003123_paternal_imprinting | 1.14527671 |
| 58 | MP0003631_nervous_system_phenotype | 1.13409830 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.12926635 |
| 60 | MP0005171_absent_coat_pigmentation | 1.11285676 |
| 61 | MP0001177_atelectasis | 1.09540212 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.09093953 |
| 63 | MP0008874_decreased_physiological_sensi | 1.08567866 |
| 64 | * MP0003075_altered_response_to | 1.07289330 |
| 65 | MP0003283_abnormal_digestive_organ | 1.05744763 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.05370324 |
| 67 | MP0000751_myopathy | 1.03655212 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.03190905 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.00957759 |
| 70 | MP0002152_abnormal_brain_morphology | 1.00270115 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.00004767 |
| 72 | MP0006276_abnormal_autonomic_nervous | 0.98384893 |
| 73 | MP0001958_emphysema | 0.98161231 |
| 74 | MP0004142_abnormal_muscle_tone | 0.97416765 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.96556310 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 0.96370382 |
| 77 | MP0004130_abnormal_muscle_cell | 0.95572139 |
| 78 | MP0001666_abnormal_nutrient_absorption | 0.94472798 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.92832521 |
| 80 | MP0001188_hyperpigmentation | 0.92656337 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.92516145 |
| 82 | MP0005275_abnormal_skin_tensile | 0.92367118 |
| 83 | * MP0002118_abnormal_lipid_homeostasis | 0.91327002 |
| 84 | MP0003045_fibrosis | 0.89260765 |
| 85 | MP0003690_abnormal_glial_cell | 0.88704082 |
| 86 | MP0000604_amyloidosis | 0.86923144 |
| 87 | MP0005535_abnormal_body_temperature | 0.86860864 |
| 88 | MP0004085_abnormal_heartbeat | 0.86745159 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.85478808 |
| 90 | MP0004510_myositis | 0.84821269 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.83472156 |
| 92 | MP0002090_abnormal_vision | 0.82983505 |
| 93 | MP0003252_abnormal_bile_duct | 0.81905964 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.80833073 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.80315116 |
| 96 | MP0003122_maternal_imprinting | 0.80244665 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.79085602 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.77123702 |
| 99 | MP0002229_neurodegeneration | 0.77106984 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.74440737 |
| 101 | MP0000920_abnormal_myelination | 0.73704208 |
| 102 | MP0003868_abnormal_feces_composition | 0.73105278 |
| 103 | MP0003634_abnormal_glial_cell | 0.72807530 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.72743442 |
| 105 | MP0001756_abnormal_urination | 0.72504545 |
| 106 | MP0005503_abnormal_tendon_morphology | 0.71071717 |
| 107 | MP0002933_joint_inflammation | 0.70582833 |
| 108 | MP0000026_abnormal_inner_ear | 0.70574686 |
| 109 | MP0003632_abnormal_nervous_system | 0.70279653 |
| 110 | MP0001664_abnormal_digestion | 0.69581677 |
| 111 | MP0004133_heterotaxia | 0.69215250 |
| 112 | MP0002254_reproductive_system_inflammat | 0.68609036 |
| 113 | MP0005409_darkened_coat_color | 0.68597567 |
| 114 | MP0009840_abnormal_foam_cell | 0.68540842 |
| 115 | MP0004484_altered_response_of | 0.67256071 |
| 116 | MP0005448_abnormal_energy_balance | 0.66364984 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.65387056 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.64074375 |
| 119 | MP0005499_abnormal_olfactory_system | 0.63715504 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.63715504 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.61241285 |
| 122 | MP0004742_abnormal_vestibular_system | 0.59870079 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.59163029 |
| 124 | MP0004043_abnormal_pH_regulation | 0.58352900 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.57333089 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.56787372 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.56617043 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.55291911 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.54595747 |
| 130 | MP0004233_abnormal_muscle_weight | 0.54479542 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.53694178 |
| 132 | MP0001943_abnormal_respiration | 0.52651315 |
| 133 | MP0002752_abnormal_somatic_nervous | 0.51733622 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.50249577 |
| 135 | MP0010769_abnormal_survival | 0.47483122 |
| 136 | MP0003956_abnormal_body_size | 0.47247538 |
| 137 | MP0010770_preweaning_lethality | 0.44442870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.37637876 |
| 2 | Myokymia (HP:0002411) | 8.11136934 |
| 3 | Focal seizures (HP:0007359) | 6.10244150 |
| 4 | Visual hallucinations (HP:0002367) | 5.34771649 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.16540485 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.89106328 |
| 7 | Atonic seizures (HP:0010819) | 4.53822579 |
| 8 | Febrile seizures (HP:0002373) | 4.29592907 |
| 9 | Absence seizures (HP:0002121) | 4.14623377 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.96532808 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.95487626 |
| 12 | Action tremor (HP:0002345) | 3.81778621 |
| 13 | Dialeptic seizures (HP:0011146) | 3.80888617 |
| 14 | Bronchomalacia (HP:0002780) | 3.77336759 |
| 15 | Poor eye contact (HP:0000817) | 3.75047960 |
| 16 | Complement deficiency (HP:0004431) | 3.71349778 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.71299497 |
| 18 | Ankle clonus (HP:0011448) | 3.55376681 |
| 19 | Broad-based gait (HP:0002136) | 3.54581655 |
| 20 | Depression (HP:0000716) | 3.48020769 |
| 21 | Glomerulonephritis (HP:0000099) | 3.41933400 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.39660161 |
| 23 | Abnormal social behavior (HP:0012433) | 3.39255204 |
| 24 | Impaired social interactions (HP:0000735) | 3.39255204 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.37277020 |
| 26 | Anxiety (HP:0000739) | 3.31473471 |
| 27 | Dysdiadochokinesis (HP:0002075) | 3.29566216 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.28097770 |
| 29 | Alacrima (HP:0000522) | 3.25863992 |
| 30 | Dysmetria (HP:0001310) | 3.23579872 |
| 31 | Joint hemorrhage (HP:0005261) | 3.23047157 |
| 32 | Torticollis (HP:0000473) | 3.21984901 |
| 33 | Papilledema (HP:0001085) | 3.21365932 |
| 34 | Sleep apnea (HP:0010535) | 3.16487521 |
| 35 | Postural instability (HP:0002172) | 3.16334693 |
| 36 | Peripheral hypomyelination (HP:0007182) | 3.06080532 |
| 37 | Amblyopia (HP:0000646) | 3.05431706 |
| 38 | Annular pancreas (HP:0001734) | 3.01376951 |
| 39 | Abnormality of the lower motor neuron (HP:0002366) | 3.01122778 |
| 40 | Abnormal eating behavior (HP:0100738) | 3.00929122 |
| 41 | Focal dystonia (HP:0004373) | 2.98945204 |
| 42 | Hyperventilation (HP:0002883) | 2.98833880 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.89180237 |
| 44 | Truncal ataxia (HP:0002078) | 2.87970480 |
| 45 | Mutism (HP:0002300) | 2.83907221 |
| 46 | Urinary urgency (HP:0000012) | 2.81689974 |
| 47 | Stereotypic behavior (HP:0000733) | 2.80755504 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.80580070 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.78861808 |
| 50 | Abnormality of complement system (HP:0005339) | 2.73742009 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.73006837 |
| 52 | Prolonged partial thromboplastin time (HP:0003645) | 2.70654672 |
| 53 | Morphological abnormality of the inner ear (HP:0011390) | 2.69635206 |
| 54 | Genetic anticipation (HP:0003743) | 2.69455001 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.68140784 |
| 56 | Craniofacial dystonia (HP:0012179) | 2.66476103 |
| 57 | Hemiplegia (HP:0002301) | 2.63941922 |
| 58 | Scanning speech (HP:0002168) | 2.58267443 |
| 59 | Dysmetric saccades (HP:0000641) | 2.58233426 |
| 60 | Xanthomatosis (HP:0000991) | 2.58230417 |
| 61 | Intention tremor (HP:0002080) | 2.56980808 |
| 62 | Bradykinesia (HP:0002067) | 2.56578776 |
| 63 | Impaired vibratory sensation (HP:0002495) | 2.52034928 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.50663876 |
| 65 | Spastic gait (HP:0002064) | 2.49753465 |
| 66 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49163047 |
| 67 | Megalencephaly (HP:0001355) | 2.45820976 |
| 68 | Hemiparesis (HP:0001269) | 2.44186466 |
| 69 | Resting tremor (HP:0002322) | 2.43892960 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.42933879 |
| 71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42537872 |
| 72 | Pointed chin (HP:0000307) | 2.41672561 |
| 73 | Drooling (HP:0002307) | 2.40638123 |
| 74 | Excessive salivation (HP:0003781) | 2.40638123 |
| 75 | Epileptiform EEG discharges (HP:0011182) | 2.39974703 |
| 76 | Akinesia (HP:0002304) | 2.39610506 |
| 77 | Ankyloglossia (HP:0010296) | 2.39374246 |
| 78 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36815824 |
| 79 | Hypoplasia of the iris (HP:0007676) | 2.36423865 |
| 80 | Status epilepticus (HP:0002133) | 2.30570223 |
| 81 | Progressive inability to walk (HP:0002505) | 2.30485593 |
| 82 | Bundle branch block (HP:0011710) | 2.29883771 |
| 83 | Diplopia (HP:0000651) | 2.29326474 |
| 84 | Abnormality of binocular vision (HP:0011514) | 2.29326474 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.26716178 |
| 86 | Nephritis (HP:0000123) | 2.25894233 |
| 87 | Decreased lacrimation (HP:0000633) | 2.22040695 |
| 88 | Lymphangioma (HP:0100764) | 2.22003673 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21732963 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.19638347 |
| 91 | Heterochromia iridis (HP:0001100) | 2.16678154 |
| 92 | Lower limb muscle weakness (HP:0007340) | 2.15329632 |
| 93 | Incomplete penetrance (HP:0003829) | 2.14179162 |
| 94 | Obstructive sleep apnea (HP:0002870) | 2.13301323 |
| 95 | Fetal akinesia sequence (HP:0001989) | 2.11608530 |
| 96 | Generalized myoclonic seizures (HP:0002123) | 2.10927620 |
| 97 | Hypsarrhythmia (HP:0002521) | 2.10863962 |
| 98 | Absent speech (HP:0001344) | 2.08314895 |
| 99 | Hypercholesterolemia (HP:0003124) | 2.04213468 |
| 100 | Cerebral hypomyelination (HP:0006808) | 2.01671628 |
| 101 | Abnormal EKG (HP:0003115) | 1.99390110 |
| 102 | Epidermoid cyst (HP:0200040) | 1.98976243 |
| 103 | Termporal pattern (HP:0011008) | 1.97108300 |
| 104 | Insidious onset (HP:0003587) | 1.97108300 |
| 105 | Insomnia (HP:0100785) | 1.95872356 |
| 106 | Turricephaly (HP:0000262) | 1.94738985 |
| 107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.93431580 |
| 108 | Inability to walk (HP:0002540) | 1.92814068 |
| 109 | Pigmentary retinal degeneration (HP:0001146) | 1.92667448 |
| 110 | Lower limb asymmetry (HP:0100559) | 1.92329006 |
| 111 | Gait ataxia (HP:0002066) | 1.90274189 |
| 112 | Mitral stenosis (HP:0001718) | 1.89703703 |
| 113 | Clonus (HP:0002169) | 1.89504120 |
| 114 | Abnormality of the periventricular white matter (HP:0002518) | 1.89048530 |
| 115 | Rapidly progressive (HP:0003678) | 1.88668992 |
| 116 | Stridor (HP:0010307) | 1.86529073 |
| 117 | Right ventricular cardiomyopathy (HP:0011663) | 1.86318187 |
| 118 | Delusions (HP:0000746) | 1.85935797 |
| 119 | Abnormality of saccadic eye movements (HP:0000570) | 1.84586413 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 1.83376582 |
| 121 | Shallow orbits (HP:0000586) | 1.82694951 |
| 122 | Abnormality of oral frenula (HP:0000190) | 1.81846780 |
| 123 | Increased circulating renin level (HP:0000848) | 1.81440413 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 1.81385980 |
| 125 | Rigidity (HP:0002063) | 1.80827211 |
| 126 | Vascular calcification (HP:0004934) | 1.80381463 |
| 127 | Blue irides (HP:0000635) | 1.76500606 |
| 128 | Hypobetalipoproteinemia (HP:0003563) | 1.76183098 |
| 129 | Neoplasm of the heart (HP:0100544) | 1.75944321 |
| 130 | Spontaneous abortion (HP:0005268) | 1.73612853 |
| 131 | Neonatal onset (HP:0003623) | 1.73337628 |
| 132 | Limb dystonia (HP:0002451) | 1.73246035 |
| 133 | Arterial tortuosity (HP:0005116) | 1.72487303 |
| 134 | Polyphagia (HP:0002591) | 1.70809842 |
| 135 | Skin nodule (HP:0200036) | 1.70603927 |
| 136 | Spinal canal stenosis (HP:0003416) | 1.70463208 |
| 137 | Psychosis (HP:0000709) | 1.69973859 |
| 138 | Intellectual disability, profound (HP:0002187) | 1.67647153 |
| 139 | Striae distensae (HP:0001065) | 1.67313906 |
| 140 | Prolonged QT interval (HP:0001657) | 1.65990443 |
| 141 | Apathy (HP:0000741) | 1.65756937 |
| 142 | Aplasia of the phalanges of the hand (HP:0009802) | 1.65751488 |
| 143 | Aplasia involving bones of the extremities (HP:0009825) | 1.65751488 |
| 144 | Vascular tortuosity (HP:0004948) | 1.63784862 |
| 145 | Advanced eruption of teeth (HP:0006288) | 1.63522346 |
| 146 | Aneurysm (HP:0002617) | 1.59284830 |
| 147 | Menorrhagia (HP:0000132) | 1.57744423 |
| 148 | Acanthosis nigricans (HP:0000956) | 1.57156457 |
| 149 | Abnormality of the salivary glands (HP:0010286) | 1.57011806 |
| 150 | Severe Myopia (HP:0011003) | 1.55642684 |
| 151 | Anosmia (HP:0000458) | 1.55497654 |
| 152 | Syncope (HP:0001279) | 1.50670648 |
| 153 | Neonatal death (HP:0003811) | 1.49476958 |
| 154 | Ulnar claw (HP:0001178) | 1.48810719 |
| 155 | Laryngomalacia (HP:0001601) | 1.46305559 |
| 156 | Oligomenorrhea (HP:0000876) | 1.46239120 |
| 157 | Retinal atrophy (HP:0001105) | 1.45439452 |
| 158 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.44892560 |
| 159 | Mucopolysacchariduria (HP:0008155) | 1.44892560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.92278743 |
| 2 | NTRK3 | 4.45736308 |
| 3 | MAP3K9 | 4.01691966 |
| 4 | SIK1 | 3.19311998 |
| 5 | EPHA2 | 3.08774273 |
| 6 | DAPK2 | 3.06563333 |
| 7 | KSR2 | 2.60255873 |
| 8 | PRKD3 | 2.54728526 |
| 9 | MAP3K4 | 2.54501029 |
| 10 | MINK1 | 2.43419183 |
| 11 | MAPK15 | 2.40425248 |
| 12 | RIPK4 | 2.32313694 |
| 13 | PAK6 | 2.29974694 |
| 14 | FGFR4 | 2.11340517 |
| 15 | CAMKK1 | 2.06357011 |
| 16 | MAP2K7 | 2.05355828 |
| 17 | MARK1 | 1.95945246 |
| 18 | DAPK1 | 1.91450938 |
| 19 | NTRK1 | 1.89782256 |
| 20 | NTRK2 | 1.82003253 |
| 21 | KSR1 | 1.80113220 |
| 22 | ARAF | 1.77863230 |
| 23 | MAP3K13 | 1.73853742 |
| 24 | MAP3K12 | 1.70852723 |
| 25 | MAP2K4 | 1.60638679 |
| 26 | CDK5 | 1.59501896 |
| 27 | ICK | 1.49177778 |
| 28 | FES | 1.41597412 |
| 29 | MAP3K2 | 1.40974472 |
| 30 | ERBB2 | 1.40172880 |
| 31 | PLK2 | 1.39637992 |
| 32 | STK38 | 1.38906722 |
| 33 | CDK19 | 1.33193161 |
| 34 | TNIK | 1.31072040 |
| 35 | PRPF4B | 1.29678587 |
| 36 | TAOK1 | 1.29094843 |
| 37 | SIK2 | 1.28230554 |
| 38 | TYRO3 | 1.25926746 |
| 39 | EEF2K | 1.23524456 |
| 40 | GRK5 | 1.21481713 |
| 41 | EPHA3 | 1.17967787 |
| 42 | FGFR3 | 1.16744024 |
| 43 | WNK4 | 1.15428774 |
| 44 | TRIB3 | 1.14543936 |
| 45 | PRKCG | 1.13260606 |
| 46 | RAF1 | 1.11762475 |
| 47 | PTK2B | 1.06824173 |
| 48 | FGFR2 | 1.03515674 |
| 49 | CASK | 1.02411839 |
| 50 | CAMK1 | 1.01879374 |
| 51 | CAMKK2 | 1.01420032 |
| 52 | MAP3K3 | 1.00725462 |
| 53 | MAP3K6 | 0.96146205 |
| 54 | PRKCH | 0.94100879 |
| 55 | UHMK1 | 0.93567758 |
| 56 | CAMK2A | 0.92713637 |
| 57 | STK11 | 0.90572912 |
| 58 | CDK18 | 0.90440494 |
| 59 | CDK15 | 0.89353983 |
| 60 | PIK3CA | 0.88673559 |
| 61 | BMPR2 | 0.86898959 |
| 62 | MAPK13 | 0.84085137 |
| 63 | CDK14 | 0.83504403 |
| 64 | CAMK2B | 0.83355180 |
| 65 | SGK223 | 0.80375492 |
| 66 | SGK494 | 0.80375492 |
| 67 | PINK1 | 0.80235273 |
| 68 | ALK | 0.79845964 |
| 69 | MAP3K1 | 0.78731737 |
| 70 | RET | 0.78555273 |
| 71 | CDK11A | 0.77784968 |
| 72 | EPHB1 | 0.77345467 |
| 73 | PNCK | 0.76144890 |
| 74 | PDK1 | 0.75790252 |
| 75 | TESK1 | 0.75212799 |
| 76 | LATS2 | 0.74315438 |
| 77 | MAPKAPK3 | 0.74209965 |
| 78 | OXSR1 | 0.74028903 |
| 79 | PDPK1 | 0.73509757 |
| 80 | PKN1 | 0.73285436 |
| 81 | MAP3K11 | 0.73257402 |
| 82 | MARK2 | 0.72057199 |
| 83 | SGK1 | 0.71692062 |
| 84 | PAK3 | 0.70937124 |
| 85 | PRKAA2 | 0.70509277 |
| 86 | HIPK2 | 0.70074592 |
| 87 | RPS6KA2 | 0.66365016 |
| 88 | SGK3 | 0.65255285 |
| 89 | SGK2 | 0.64888688 |
| 90 | MAPK12 | 0.62701837 |
| 91 | MAP3K7 | 0.61950197 |
| 92 | LMTK2 | 0.61905192 |
| 93 | MAP2K6 | 0.61742970 |
| 94 | DAPK3 | 0.60209815 |
| 95 | RIPK1 | 0.59407744 |
| 96 | ERN1 | 0.59273954 |
| 97 | TNK2 | 0.59066360 |
| 98 | NEK6 | 0.57877464 |
| 99 | NEK1 | 0.57796394 |
| 100 | PRKAA1 | 0.56530947 |
| 101 | PDGFRA | 0.56522866 |
| 102 | PTK2 | 0.54043032 |
| 103 | FER | 0.52845487 |
| 104 | DMPK | 0.52734033 |
| 105 | JAK1 | 0.52585243 |
| 106 | MAP2K1 | 0.52278895 |
| 107 | ROCK1 | 0.52248571 |
| 108 | DYRK1A | 0.50412454 |
| 109 | TIE1 | 0.49952332 |
| 110 | PHKG2 | 0.48217016 |
| 111 | PHKG1 | 0.48217016 |
| 112 | RPS6KA3 | 0.47965985 |
| 113 | CHUK | 0.47644657 |
| 114 | CAMK4 | 0.46823110 |
| 115 | PRKCZ | 0.46669557 |
| 116 | PRKD1 | 0.46075207 |
| 117 | BRSK1 | 0.45241219 |
| 118 | FYN | 0.44906523 |
| 119 | MAPK8 | 0.44900769 |
| 120 | SMG1 | 0.43543584 |
| 121 | ROCK2 | 0.43422475 |
| 122 | MYLK | 0.43169640 |
| 123 | CAMK2G | 0.42025858 |
| 124 | WNK1 | 0.41537504 |
| 125 | PRKCE | 0.41352258 |
| 126 | MAPK10 | 0.40584977 |
| 127 | CAMK2D | 0.40427298 |
| 128 | FGR | 0.40155438 |
| 129 | MOS | 0.39729987 |
| 130 | CDC42BPA | 0.39520672 |
| 131 | CSNK1G2 | 0.38783722 |
| 132 | NME1 | 0.37082229 |
| 133 | BRAF | 0.35863078 |
| 134 | PRKD2 | 0.34259750 |
| 135 | BMX | 0.33139435 |
| 136 | CCNB1 | 0.32444132 |
| 137 | DDR2 | 0.32055408 |
| 138 | SCYL2 | 0.28890613 |
| 139 | PRKCB | 0.28304476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.45730752 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.18926419 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.98354002 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74471754 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73008512 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59121784 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59066210 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53563187 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52024807 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.50008444 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26995550 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.23568695 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18949403 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16530763 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13278387 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.99161830 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.98736056 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94758336 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.93022703 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91402204 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.82242973 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78615482 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75137888 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.71394363 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69537415 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64215934 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.57968242 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.55412944 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.50775100 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49206616 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48832721 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.48401262 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37605665 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35326778 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.34681984 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33604187 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33603626 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33277583 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31060058 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29709119 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29005119 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.25693719 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19031002 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17157986 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16952184 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14821226 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12382858 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.12313493 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10943808 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07402591 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06730071 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06025563 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.04588135 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02398689 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01834500 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.01393405 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00957370 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00133252 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98902612 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96995641 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.96904020 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94727661 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94642099 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89642593 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89023506 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88081785 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87536258 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86569279 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86204415 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86167551 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85097860 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84298900 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84200223 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82523572 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82082455 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80753682 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80549981 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79728922 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79062157 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78812844 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75938398 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73898821 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71464621 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71298498 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69316575 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68932439 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68858830 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68769018 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67022944 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66824890 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66816327 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64435052 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.62082400 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60733941 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59620905 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57688787 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56442658 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56334899 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55851242 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55764101 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.55703018 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54315411 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53259673 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.52302407 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.52147546 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52088594 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52025601 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51225069 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50559061 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.49770970 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49228800 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48972663 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.48451903 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.47743186 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47318472 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47261059 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45672531 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.45346821 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44683262 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44076193 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43483218 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42092122 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41598826 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39627927 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38005049 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37519536 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35858405 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35686963 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35373123 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35306289 |
| 131 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34806535 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33441998 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31060020 |
| 134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29509631 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28507239 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.28044508 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27011678 |
| 138 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25386353 |
| 139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24159719 |

